3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
16
Liver Neoplasms
7
Pancreatic Neoplasms
4
Cholangiocarcinoma
4
Colorectal Neoplasms
3
Thyroid Nodule
2
Thyroid Diseases
2
Neoplasm Metastasis
2
Gallbladder Neoplasms
2
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Stomach Neoplasms
1
Solid Tumor Including Thyroid, Bone, Liver, Pancreas
1
Recurrence
1
Papillary Thyroid Microcarcinoma
1
Neoplasms, Glandular and Epithelial
1
Neoplasms
1
NSCLC
1
Lung Neoplasms
1
Hypertension, Portal
1
Hyperaldosteronism
1
Hepatitis B
1
Hepatic Metastasis of Colorectal Cancer
1
Head and Neck Neoplasms
1
HCC
1
Colorectal Cancer Liver Metastases
1
Colonic Neoplasms
1
Cholestasis
1
Carcinoma, Non-Small-Cell Lung
1
Cancer Pain
1
Interventions
olaparib
1
niraparib
1
anlotinib
1
Sorafenib
1
Radiofrequency Ablation
1
Ocoxin
1
Chemoradiotherapy
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Neoplasms, Glandular and Epithelial
×
Radiofrequency Ablation
×
Clear all
NCT02192671
2022-01-18
HR-HCC/PHT
Guangxi Medical University
Phase 3
Unknown
120 enrolled